NASAL SPRAY: GAME-CHANGER FOR ERECTILE DYSFUNCTION

madman

Super Moderator
US launch 2026!

UP YOUR NOSE AND UP IT GOES LOL!

* It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market




To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Tylah Tully chats with LTR Pharma (ASX:LTP) executive chairman Lee Rodne about its successful pre-Investigational New Drug Application meeting with the US FDA, a major milestone in the development of its erectile dysfunction product SPONTAN.It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market, valued over $6 billion dollars.
 
 

Online statistics

Members online
2
Guests online
144
Total visitors
146

Latest posts

Back
Top